#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3819815	B	Activation of TREK1 (unknown origin) expressed in Xenopus oocytes assessed as increase in channel currents at 100 uM relative to control	Homo sapiens	3	ALA3817738	cell-based format	Scientific Literature
2.	ALA3819816	B	Activation of TREK1 (unknown origin) expressed in Xenopus oocytes assessed as increase in channel currents	Homo sapiens	3	ALA3817738	cell-based format	Scientific Literature
3.	ALA3993349	B	Agonist activity at human TREK1 expressed in HEK293 cells assessed as increase in K+ current at 100 uM measured at +60 mV by whole-cell patch clamp method relative to control	Homo sapiens	29	ALA3992520	cell-based format	Scientific Literature
4.	ALA3993357	F	Antinociceptive activity in CD1 mouse assessed as increase in thermal-stimulus induced paw withdrawal latency at 60 mg/kg, sc measured after 30 mins by hot plate method relative to control	Mus musculus	56	ALA3992520	organism-based format	Scientific Literature
5.	ALA3993358	F	Antinociceptive activity in CD1 mouse assessed as increase in thermal-stimulus induced paw withdrawal latency at 60 mg/kg, sc measured after 45 mins by hot plate method relative to control	Mus musculus	56	ALA3992520	organism-based format	Scientific Literature
6.	ALA4419063	B	Activation of K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	31	ALA4418913	cell-based format	Patent Bioactivity Data
7.	ALA4419064	B	Activation of K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at -80 mV holding potential by two-electrode voltage clamp assay relative to untreated control	Homo sapiens	7	ALA4418913	cell-based format	Patent Bioactivity Data
8.	ALA4419071	B	Reversible modulatory activity at K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at 100 uM at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	2	ALA4418913	cell-based format	Patent Bioactivity Data
9.	ALA4419084	B	Activation of K2P10.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	2	ALA4418913	cell-based format	Patent Bioactivity Data
10.	ALA4419095	B	Activation of K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at 400 uM by two-electrode voltage clamp assay	Homo sapiens	3	ALA4418913	cell-based format	Patent Bioactivity Data
11.	ALA4419098	B	Activation of Kv7.2 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents by two-electrode voltage clamp assay	Homo sapiens	1	ALA4418913	cell-based format	Patent Bioactivity Data
12.	ALA4419103	B	Activation of K2P10.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at 500 uM at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	1	ALA4418913	cell-based format	Patent Bioactivity Data
13.	ALA4419106	B	Activation of K2P3.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at 500 uM at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	1	ALA4418913	cell-based format	Patent Bioactivity Data
14.	ALA4419107	B	Activation of Kv7.2 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at 500 uM by two-electrode voltage clamp assay	Homo sapiens	1	ALA4418913	cell-based format	Patent Bioactivity Data
15.	ALA4421806	B	Activation of K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	30	ALA4421719	cell-based format	Patent Bioactivity Data
16.	ALA4421811	B	Activation of K2P10.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at -80 mV holding potential by two-electrode voltage clamp assay	Homo sapiens	2	ALA4421719	cell-based format	Patent Bioactivity Data
17.	ALA4421812	B	Selectivity index, ratio of IC50 for inhibition of Trk1p (unknown origin) expressed in SGY1528 yeast cells assessed as inhibition of cell growth by alamar blue dye based assay to IC50 for inhibition of K2P2.1 (unknown origin) expressed in SGY1528 yeast cells assessed as inhibition of cell growth by alamar blue dye based assay	Homo sapiens	2	ALA4421719	cell-based format	Patent Bioactivity Data
18.	ALA4421820	B	Inhibition of K2P2.1 (unknown origin) expressed in SGY1528 yeast cells assessed as inhibition of cell growth at 10 uM incubated for 24 hrs by alamar blue dye based assay relative to control	Homo sapiens	5	ALA4421719	cell-based format	Patent Bioactivity Data
19.	ALA4421824	B	Activation of K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at +40 mV holding potential at 400 uM by two-electrode voltage clamp assay	Homo sapiens	2	ALA4421719	cell-based format	Patent Bioactivity Data
20.	ALA4421828	B	Reversible activation of K2P2.1 (unknown origin) expressed in Xenopus oocytes assessed as effect on channel currents at 100 uM at -80 mV holding potential by two-electrode voltage clamp assay relative to control	Homo sapiens	1	ALA4421719	cell-based format	Patent Bioactivity Data